LianBio (NASDAQ:LIAN – Get Free Report)’s stock price shot up 2% during mid-day trading on Wednesday . The company traded as high as $0.39 and last traded at $0.38. 51,338 shares traded hands during mid-day trading, a decline of 95% from the average session volume of 1,037,083 shares. The stock had previously closed at $0.37.
LianBio Trading Up 2.0%
The business has a fifty day simple moving average of $0.21 and a two-hundred day simple moving average of $0.23. The company has a market cap of $41.06 million, a PE ratio of -0.47 and a beta of 0.23.
About LianBio
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis and meibomian gland disease; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor and NX-13 for ulcerative colitis and Crohn's disease; LYR-210 for chronic rhinosinusitis; and Sisunatovir for respiratory syncytical virus.
Recommended Stories
- Five stocks we like better than LianBio
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- $30B AI Opportunity: Will It Power Meta’s Next Surge?
- A Deeper Look at Bid-Ask Spreads
- Microsoft Could Rally as EU Antitrust Case Nears Resolution
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Intel Refocuses: NEX Sale and Foundry Pivot Signal New Era
Receive News & Ratings for LianBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LianBio and related companies with MarketBeat.com's FREE daily email newsletter.
